October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously ...
October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate companies ...
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap High Resolution Imaging and Mapping System and the AcQMap 3-D Imaging and Mapping Catheter for use in patients for whom electrophysiology procedures have been prescribed. The company plans to introduce initial commercial systems to U.S. customers in early 2018.
October 23, 2017 — Claret Medical announced that it has closed on a Series C financing of $14.5 million led by ...
October 23, 2017 — University of North Carolina (UNC) School of Medicine cardiologist Anil Gehi, M.D., will use a $1.7 ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A discussion with Mario Goessl, M.D., Ph.D., director of research and education at the Minneapolis Heart Institute. He ...
October 23, 2017 — The first patient implant has taken place in the APOLLO Trial, the pivotal trial designed to evaluate ...
October 23, 2017 – The U.S. Food and Drug Administration (FDA) has cleared Abbott’s Confirm Rx Insertable Cardiac ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation Center in Boston. The Center will be home to the Cardiovascular Medicine Innovation team, led by Calum MacRae, M.D., Ph.D., chief of cardiovascular medicine at Brigham and Women’s Hospital (BWH) who, leveraging the latest technologies and scientific advances, will continue their work for One Brave Idea, the $75 million research enterprise charged with bringing an end to coronary heart disease and its consequences.
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart ...
Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of subsequent cardiovascular events in women, but not in men, according to research presented at The Liver Meeting held by the American Association for the Study of Liver Diseases.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financing ...
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare ...
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian and other ethnic backgrounds, according to a new study. The study, the largest of its kind, was published in JAMA Cardiology by researchers from the Perelman school of Medicine at the University of Pennsylvania.